seri
novel
ketoprofen
deriv
bear
amid
carbam
function
prepar
use
benzotriazol
method
carboxyl
hydroxi
group
activ
select
reduct
ketoprofen
produc
hydroxi
deriv
reaction
one
two
mole
carboxyl
acid
chlorid
gave
benzotriazol
deriv
respect
compound
variou
amin
afford
amidocarbam
antioxid
screen
reveal
prepar
compound
possess
excel
lipid
peroxid
inhibit
mm
concentr
higher
deriv
bear
aromat
cycloalkyl
heterocycl
substitu
two
compound
also
show
high
soybean
lipoxygenas
inhibit
activ
respect
hand
amidocarbam
deriv
ketoprofen
show
weak
reduc
activ
radic
select
antivir
effect
note
test
compound
broad
varieti
dna
rna
virus
compound
endow
moder
ic
lm
cytostat
activ
ketoprofen
ket
nonsteroid
antiinflammatori
drug
nsaid
pronounc
analges
antipyret
properti
numer
ketoprofen
deriv
synthes
order
minim
sideeffect
prolong
plasma
halflif
increas
solubl
bonina
et
al
bonina
et
al
b
amid
prove
use
prodrug
other
possess
antiinflammatori
activ
independ
parent
compound
demonstr
amid
nsaid
improv
select
toward
kalgutkar
et
al
modif
carboxyl
group
hydroxam
acid
lead
inhibit
cyclooxygenas
two
enzym
crucial
inflammatori
process
flynn
et
al
muri
et
al
glycin
amid
ketoprofen
sever
wellknown
nsaid
significantli
less
irrit
gastric
mucosa
antiinflammatori
activ
compar
parent
drug
shanbhag
et
al
singh
et
al
ketoprofen
glycin
methyl
ester
higher
antiinflammatori
analges
activ
parent
drug
dhaneshwar
chaturvedi
ketoprofenamid
heterocycl
residu
pyridyl
thiazolyl
also
possess
signific
analges
antiinflammatori
activ
spickett
et
al
ketoprofen
ketoprofen
ester
bi
hydroxyalkylthio
alkan
use
treatment
prevent
atherosclerosi
lafon
numer
studi
suggest
nsaid
promis
anticanc
drug
well
may
associ
reduc
risk
colon
lung
liver
type
cancer
thun
et
al
sivaksear
et
al
previou
research
potenc
amid
hydroxam
acid
deriv
ketoprofen
relat
nsaid
cytostat
antioxid
agent
screen
zovko
et
al
et
al
wittin
et
al
articl
extens
literatur
data
describ
effect
carboxyl
group
derivat
knowledg
modif
carboxyl
carbonyl
function
ketoprofen
molecul
studi
articl
seri
novel
deriv
ketoprofen
bear
amid
carbam
moieti
prepar
character
screen
antioxid
cytostat
antivir
activ
chemistri
benzotriazolid
b
prepar
reduc
ketoprofen
deriv
carboxyl
acid
chlorid
follow
previous
develop
procedur
scheme
butula
mladar
zorc
et
al
reaction
perform
one
equival
chlorid
product
free
hydroxi
group
obtain
yield
reaction
carri
two
equival
chlorid
main
product
benzotriazolid
carboxyl
hydroxi
group
acyl
minor
amount
product
detect
well
even
reaction
perform
excess
chlorid
reaction
run
room
temperatur
order
avoid
benzotriazolid
polycondens
compound
prepar
reaction
benzotriazolid
two
equival
appropri
amin
presenc
five
equival
triethylamin
scheme
reaction
perform
toluen
room
temperatur
h
triethylamin
form
water
solubl
salt
benzotriazol
byproduct
reaction
readili
extract
water
structur
compound
b
deduc
analysi
ir
hand
cnmr
spectra
confirm
element
analysi
chemic
shift
consist
propos
structur
novel
compound
fig
tabl
interact
examin
compound
stabl
free
radic
dpph
studi
interact
dpph
indic
radic
scaveng
abil
ironfre
system
interact
monitor
min
two
concentr
dpph
mm
ketoprofen
prototyp
compound
benzotriazolid
well
test
compound
present
low
interact
valu
result
shown
tabl
compound
evalu
inhibit
soybean
lipoxygenas
lox
uv
absorb
base
enzym
assay
pontiki
hadjipavloulitina
lipoxygenas
oxid
certain
fatti
acid
specif
posit
hydroperoxid
precursor
leukotrien
contain
conjug
trien
structur
ie
soybean
lipoxygenas
convert
linol
acid
leukotrien
play
import
role
mediat
varieti
inflammatori
allerg
process
et
al
inhibitor
lox
attract
attent
initi
potenti
agent
treatment
inflammatori
allerg
diseas
therapeut
potenti
expand
certain
type
cancer
cardiovascular
diseas
pontiki
hadjipavloulitina
lox
inhibitor
antioxid
free
radic
scaveng
sinc
lipoxygen
occur
via
carboncentr
radic
muller
perus
ic
valu
show
compound
activ
far
follow
compound
ic
lm
tabl
obviou
aromat
cycloalkyl
deriv
potent
lipoxygenas
inhibitor
amidocarbam
azo
compound
gener
free
radic
spontan
thermal
decomposit
use
free
radic
product
studi
vitro
water
solubl
azo
compound
azobi
dihydrochlorid
aaph
extens
use
clean
control
sourc
thermal
produc
alkylperoxyl
free
radic
studi
aaph
use
free
radic
initi
follow
oxid
chang
linol
acid
conjug
dien
hydroperoxid
result
indic
compound
excel
inhibitor
lipid
peroxid
lp
significantli
higher
tabl
inhibit
found
concentr
depend
regress
analysi
lp
inhibit
lm
reveal
overal
molar
refract
cmr
main
physicochem
paramet
influenc
inhibit
linear
cmr
model
suggest
compound
high
cmr
valu
activ
correl
lipophil
found
log
lp
cmr
n
r
r
q
f
antivir
evalu
perform
broad
seri
dna
rna
virus
list
experiment
section
antivir
effect
note
test
compound
virus
evalu
subtox
compound
concentr
data
shown
show
minor
antivir
activ
vesicular
stomat
viru
hela
cell
cultur
ec
lm
sindbi
viru
ec
lm
punta
toro
viru
vero
cell
cultur
ec
lm
howev
activ
found
compound
concentr
close
cytostat
activ
cc
lm
tabl
point
toxic
rather
specif
antivir
effect
compound
also
evalu
cytostat
activ
murin
leukaemia
murin
mammari
carcinoma
human
tlymphoblast
cem
cell
cultur
inhibitori
concentr
test
compound
rank
lm
depend
natur
compound
tumour
cell
line
evalu
tabl
major
compound
show
ic
valu
around
lm
ie
point
rel
minor
role
rsubstitu
core
structur
cytostat
na
b
na
compound
concentr
requir
inhibit
tumour
cell
prolifer
b
activ
report
experiment
condit
activ
long
bulki
lipophil
cyclic
entiti
present
also
presenc
amid
group
might
play
import
role
eventu
exert
cytostat
potenti
seri
novel
ketoprofen
amidocarbam
deriv
prepar
screen
antioxid
antivir
cytostat
activ
antioxid
screen
reveal
prepar
compound
possess
excel
lp
inhibit
compound
also
show
high
soybean
lipoxygenas
inhibit
activ
select
antivir
effect
note
test
compound
broad
varieti
dna
rna
virus
compound
endow
moder
cytostat
activ
melt
point
determin
stuart
melt
point
apparatu
uncorrect
ir
spectra
record
ftir
perkin
elmer
paragon
spectromet
hand
cnmr
spectra
record
varian
gemini
spectromet
oper
mhz
h
c
nuclei
respect
sampl
measur
dmsod
solut
nmr
tube
chemic
shift
refer
tm
coupl
constant
j
given
hz
element
analysi
determin
thinlay
chromatographi
precoat
merck
silica
gel
solvent
system
cyclohexaneethyl
acetatemethanol
use
spot
visual
shortwav
uv
light
iodin
vapour
column
chromatographi
perform
merck
silica
gel
mm
cyclohexaneethyl
acet
eluent
oethylhydroxylamin
hydrochlorid
obtain
fluka
ketoprofen
pliva
chemic
purchas
sigmaaldrich
solvent
analyt
grade
puriti
dri
prior
use
solut
benzotriazol
g
mmol
triphosgen
g
mmol
dri
toluen
reflux
h
reaction
mixtur
evapor
reduc
pressur
crude
product
use
follow
reaction
without
purif
butula
mladar
hydroxi
phenyl
methyl
phenyl
propano
acid
prepar
catalyt
hydrogen
ketoprofen
use
h
pdc
en
tetrahydrofuran
hattori
et
al
accord
modifi
publish
procedur
allegretti
et
al
solut
g
mmol
triethylamin
ml
mmol
dri
toluen
ml
solut
chlorid
g
mmol
dri
toluen
ml
atom
enumer
given
fig
solut
g
mmol
triethylamin
ml
mmol
dri
toluen
ml
solut
chlorid
g
mmol
dri
toluen
ml
ad
dropwis
h
reaction
mixtur
stir
room
temperatur
h
wash
four
time
water
organ
layer
dri
anhydr
sodium
sulphat
filtrat
evapor
thu
obtain
crude
product
purifi
tritur
ether
yield
g
mp
ir
kbr
max
atom
enumer
given
fig
solut
benzotriazolid
g
mmol
omethylhydroxylamin
hydrochlorid
g
mmol
triethylamin
ml
mmol
toluen
ml
stir
room
temperatur
h
reaction
mixtur
extract
brine
ml
hydrochlor
acid
ml
wash
water
till
ph
organ
layer
dri
anhydr
sodium
sulphat
evapor
reduc
pressur
thu
obtain
crude
product
purifi
column
chromatographi
eluent
cyclohexaneethyl
acet
yield
g
oil
ir
film
max
solut
benzotriazolid
g
mmol
oethylhydroxylamin
hydrochlorid
g
mmol
triethylamin
ml
mmol
toluen
ml
stir
room
temperatur
h
reaction
mixtur
extract
brine
ml
hydrochlor
acid
ml
wash
water
till
ph
organ
layer
dri
anhydr
sodium
sulphat
evapor
reduc
pressur
thu
obtain
crude
product
purifi
column
chromatographi
eluent
cyclohexaneethyl
acet
yield
g
oil
ir
film
max
benzyloxycarbamoyl
ethyl
phenyl
phenyl
methyl
benzyloxycarbam
solut
benzotriazolid
g
mmol
obenzylhydroxylamin
hydrochlorid
g
mmol
triethylamin
ml
mmol
toluen
ml
stir
room
temperatur
h
reaction
mixtur
extract
brine
ml
hydrochlor
acid
ml
wash
water
till
ph
organ
layer
dri
anhydr
sodium
sulphat
evapor
reduc
pressur
crude
product
purifi
column
chromatographi
eluent
cyclohexaneethyl
acet
yield
g
mp
ir
kbr
max
cyclopentylcarbamoyl
ethyl
phenyl
phenyl
methyl
cyclopentylcarbam
solut
benzotriazolid
g
mmol
cyclopentylamin
ml
mmol
triethylamin
ml
mmol
toluen
ml
stir
room
temperatur
h
reaction
mixtur
extract
brine
ml
hydrochlor
acid
ml
wash
water
till
ph
organ
layer
dri
anhydr
sodium
sulphat
evapor
reduc
pressur
cyclohexylcarbamoyl
ethyl
phenyl
phenyl
methyl
cyclohexylcarbam
solut
benzotriazolid
g
mmol
cyclohexylamin
ml
mmol
triethylamin
ml
mmol
toluen
ml
stir
room
temperatur
h
reaction
mixtur
extract
brine
ml
hydrochlor
acid
ml
wash
water
till
ph
organ
layer
dri
anhydr
sodium
sulphat
evapor
reduc
pressur
crude
product
tritur
ether
sever
time
yield
g
mp
ir
kbr
max
solut
benzotriazolid
g
mmol
cyclohexanemethylamin
ml
mmol
triethylamin
ml
mmol
toluen
ml
stir
room
temperatur
h
reaction
mixtur
extract
brine
ml
hydrochlor
acid
ml
wash
water
till
ph
organ
layer
dri
anhydr
sodium
sulphat
evapor
reduc
pressur
crude
product
tritur
ether
sever
time
yield
g
mp
ir
kbr
max
h
n
found
c
h
n
benzylcarbamoyl
ethyl
phenyl
phenyl
methyl
benzylcarbam
solut
benzotriazolid
g
mmol
benzylamin
ml
mmol
triethylamin
ml
mmol
toluen
ml
stir
room
temperatur
h
reaction
mixtur
extract
brine
ml
hydrochlor
acid
ml
wash
water
till
ph
organ
layer
dri
anhydr
sodium
sulphat
evapor
reduc
pressur
crude
product
tritur
ether
sever
time
yield
g
mp
ir
kbr
max
h
n
found
c
h
n
phenylethylcarbamoyl
ethyl
phenyl
phenyl
methyl
phenylethylcarbam
solut
benzotriazolid
g
mmol
phenylethylamin
ml
mmol
triethylamin
ml
mmol
toluen
ml
stir
room
temperatur
h
reaction
mixtur
extract
brine
ml
hydrochlor
acid
ml
wash
water
till
ph
organ
layer
dri
anhydr
sodium
sulphat
evapor
reduc
pressur
pure
product
obtain
tritur
ether
yield
g
oil
ir
kbr
max
h
n
found
c
h
n
phenyl
phenyl
methyl
solut
benzotriazolid
g
mmol
pyrrolidin
ml
mmol
triethylamin
ml
mmol
toluen
ml
stir
room
temperatur
h
reaction
mixtur
extract
brine
ml
hydrochlor
acid
ml
wash
water
till
ph
organ
layer
dri
anhydr
sodium
sulphat
evapor
reduc
pressur
crude
product
purifi
column
chromatographi
eluent
cyclohexaneethyl
acet
yield
g
oil
ir
film
max
phenyl
phenyl
methyl
solut
benzotriazolid
g
mmol
piperidin
ml
mmol
triethylamin
ml
mmol
toluen
ml
stir
room
temperatur
h
reaction
mixtur
extract
brine
ml
hydrochlor
acid
ml
wash
water
till
ph
organ
layer
dri
anhydr
sodium
sulphat
evapor
reduc
pressur
tritur
ether
afford
pure
product
yield
g
mp
ir
kbr
max
pontiki
hadjipavloulitina
min
absorb
record
nm
compar
appropri
standard
ndga
tabl
ethanol
use
control
vitro
experi
perform
least
triplic
standard
deviat
absorb
mean
dmso
solut
test
compound
incub
sodium
linol
mm
ml
soybean
lipoxygenas
solut
wv
salin
room
temperatur
pontiki
hadjipavloulitina
convers
sodium
linol
acid
record
nm
compar
standard
inhibitor
caffeic
acid
accord
procedur
previous
report
oxid
linol
acid
conjug
dien
hydroperoxid
aqueou
dispers
monitor
nm
et
al
aaph
use
free
radic
initi
ten
microlit
mm
linol
acid
dispers
ad
uv
cuvett
contain
ml
phosphat
buffer
ph
prethermost
oxid
reaction
initi
air
addit
mm
aaph
solut
oxid
carri
presenc
compound
final
concentr
mm
assay
antioxid
lipid
oxid
measur
presenc
level
dmso
rate
oxid
monitor
record
increas
absorpt
nm
caus
conjug
dien
hydroperoxid
result
compar
standard
inhibitor
trolox
murin
leukaemia
murin
mammari
carcinoma
human
tlymphocyt
cem
cell
suspend
cellsml
cultur
medium
cell
suspens
ad
appropri
dilut
test
compound
well
microtit
plate
incub
cem
day
cell
number
determin
use
coulter
counter
ic
defin
compound
concentr
requir
inhibit
cell
prolifer
antivir
assay
antihiv
assay
base
inhibit
virusinduc
cytopath
hel
herp
simplex
viru
type
ko
g
vaccinia
viru
vesicular
stomat
viru
vero
sindbi
coxsacki
punta
toro
viru
hela
vesicular
stomat
viru
coxsacki
viru
respiratori
syncyti
viru
felin
kidney
crandel
cell
felin
coronaviru
fecov
fipv
strain
felin
herp
viru
fehv
mdck
influenza
influenza
b
cell
cultur
virus
obtain
atcc
rockvil
md
iii
b
provid
r
c
gallo
time
nih
bethesda
md
rod
provid
l
montagni
time
pasteur
institut
pari
franc
fcov
fipv
fehv
kindli
provid
h
egberink
utrecht
netherland
confluent
cell
cultur
microtit
plate
inocul
viru
viru
dose
infect
cell
cultur
h
viru
adsorpt
period
residu
viru
remov
cell
cultur
incub
presenc
vari
concentr
lm
test
compound
viral
cytopath
record
soon
reach
complet
control
viru
infect
cell
cultur
treat
test
compound
methodolog
antihiv
assay
follow
human
cem
cellsml
cell
infect
iiib
rod
ml
seed
well
microtit
plate
contain
appropri
dilut
test
compound
day
incub
hivinduc
cem
giant
cell
format
examin
microscop
